June 9, 2016
Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema associated with rosacea in adults. Treatment with investigational dupilumab in combination with topical corticosteroids significantly improved measures of overall disease severity, according to one-year results of the LIBERTY AD CHRONOS study. Plus, new model legislation from the American Society for Dermatologic Surgery Association (ASDSA) provides state governments with a framework to permit the use of sunscreens in school and camp settings.